This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08111/identifier/pdb/
n13http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB08111/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB08111/identifier/pubchem-substance/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n6http://linked.opendata.cz/resource/drugbank/drug/DB08111/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB08111/identifier/chemspider/

Statements

Subject Item
n2:DB08111
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB08111 n13:DB08111
dcterms:title
4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol
adms:identifier
n6:DB08111 n7:LKG n8:22377538 n11:24901696 n12:99444582
n3:IUPAC-Name
n4:271B5F49-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5F4F-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5F4E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5F4B-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5F4C-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5F4D-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5F47-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5F48-363D-11E5-9242-09173F13E4C5 n4:271B5F45-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5F46-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5F55-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5F56-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5F50-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5F51-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5F53-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5F52-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5F54-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5F5B-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5F5D-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5F5E-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5F5A-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5F59-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5F5C-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5F4A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5F57-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5F58-363D-11E5-9242-09173F13E4C5